期刊
ANTIVIRAL RESEARCH
卷 88, 期 1, 页码 64-71出版社
ELSEVIER
DOI: 10.1016/j.antiviral.2010.07.006
关键词
Interferon; Influenza virus; Antiviral immunity
资金
- Canadian Institutes of Health Research [MOP-15094]
- Tier 1 Canada Research Chair
- Connaught Scholarship
- Ontario Graduate Scholarship in Science and Technology
Influenza viruses are important human pathogens, associated throughout history with worldwide outbreaks and pandemics. The antiviral effects of interferon (IFN)-alpha s/beta against influenza virus infections are well recognized, yet the mechanisms whereby IFNs exert their immunomodulatory effects on an antiinfluenza response remain ill-defined. Here, we describe the effects of IFN-beta treatment on the immune response during a respiratory influenza (A/WSN/33) A virus infection of mice. A single dose of IFN-beta (1 x 10(5) U) enhanced DC migration into the draining lymph node (DLN) on day 3 post-intranasal infection, and subsequently inhibited the migration from the lungs into the DLN of a newly identified late activator antigen-presenting cell population associated with type 2 immunity, LAPC. IFN-beta treatment polarized the immune response towards a type 1 immune response, eliciting enhanced T(H)1 effector and cytolytic T cell responses, but diminished T(H)2 effector T cell responses in both the DLN and lung tissues of influenza virus-infected mice. Associated with the polarization towards a type 1 immune response, IFN-beta treatment of mice resulted in accelerated viral clearance and diminished pulmonary eosinophilia in infected lung tissues. (C) 2010 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据